Inventor · disambiguated record
Philip Ambery
Also filed as: AMBERY PHILIP
1 granted patent·9 pending applications·0 citations·filing 2017–2024
14Inventor score
Top patents by PatentIndex Score
10 records- 0160US2022041681A1Glucagon and glp-1 co-agonists for the treatment of obesityMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 0258US10676517B2Glucagon and GLP-1 co-agonists for the treatment of obesityMEDIMMUNE LTD·Filed 2017·Granted Jun 9, 2020·0 cites·15 claims
- 0358US2024307383A1Combination of zibotentan and dapagliflozin for the treatment of proteinuria chronic kidney diseaseASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0454US2025316377A1Predicting albuminuria using machine learningASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0554US2024058331A1Combination therapies for treatment of cirrhosis with portal hypertensionASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0653US2020354426A1Glucagon and glp-1 co-agonists for the treatment of obesityMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 0747US2025253057A1Predicting disease progression in portal hypertension using machine learningASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0844US2023165856A1Dapagliflozin and ambrisentan for the prevention and treatment of covid-19ASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 0942US2024398774A1Methods of treating inflammatory diseases with a selective glucocorticoid receptor modulatorASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1034US2023012936A1Combination therapy using glucagon and glp-1 co-agonists for the treatment of obesityMEDIMMUNE LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Ambery files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →